Loading clinical trials...
Loading clinical trials...
A Phase I, Open Label, Randomized, 2-Panel, 2-Way Crossover Trial to Investigate the Pharmacokinetic Interaction Between Etravirine or TMC278 and Telaprevir at Steady-State in Healthy Subjects.
Conditions
Interventions
ETR/telaprevir
TMC278/telaprevir
+2 more
Locations
1
Belgium
Antwerp, Belgium
Start Date
March 1, 2011
Primary Completion Date
September 1, 2011
Completion Date
September 1, 2011
Last Updated
August 29, 2012
NCT04929028
NCT07071623
NCT01875588
NCT07199335
NCT03087253
NCT05419024
Lead Sponsor
Tibotec Pharmaceuticals, Ireland
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions